Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about TAU: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
Microtubule-associated protein tau (MAPT) stabilizes neuronal microtubules. Hyperphosphorylation causes detachment and aggregation into neurofibrillary tangles, a hallmark of Alzheimer disease and other tauopathies. Pathological tau spreads trans-synaptically and drives neuronal dysfunction.
| Gene Symbol | TAU |
| Chromosome | 17q21.31 |
| Protein Family | MAPT family |
| Function | is an important component in the neurobiology of neurodegenerative diseases. |
| Primary Expression | neurons, where they bind to microtubules and promote their polymerization and stability |
| Subcellular Localization | Axons, Neurons |
| Molecular Weight | 45-65 kDa (isoform dependent) |
| Amino Acids | 441 aa |
| Pathways | Extracellular Aggregation, Hyperphosphorylation, Neurofibrillary Tangle Formation, Protein Assembly, Synapse Pathology |
| GeneCards | TAU |
| Human Protein Atlas | TAU |
| NCT Number | NCT07348276 |
| Title | First-in-Human Study for the Safety and Evaluation of Two 4R Tau Ligands as Potential PET Radioligands for Imaging Tau Protein in the Brain |
| Status | RECRUITING |
| Phase | Early Phase 1 |
| Associated Diseases | AD, ALS, ALZHEIMER'S DISEASE, ALZHEIMERS_DISEASE, AMYLOID PLAQUES, AXONAL TRANSPORT |
| Known Drugs/Compounds | METFORMIN, MELATONIN, Monoclonal Antibodies, Rutin, Flavonoids, Hyperbaric Oxygen Therapy |
| Interactions | PP2A, KEAP1, NRF2, CDK5, LC3, MAPT |
| KG Connections | 5378 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
subgraph Pathology["Pathology"]
TAU["TAU"] -->|"associated with"| NEURODEGENERATION["NEURODEGENERATION"]
TAU["TAU"] -->|"associated with"| ALZHEIMER_S_DISEASE["ALZHEIMER'S DISEASE"]
TAU["TAU"] -->|"associated with"| TAUOPATHY["TAUOPATHY"]
TAU["TAU"] -->|"associated with"| Alzheimer_2["Alzheimer"]
AMYLOID["AMYLOID"] -->|"associated with"| TAU["TAU"]
MICROGLIA["MICROGLIA"] -->|"associated with"| TAU["TAU"]
NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"associated with"| TAU["TAU"]
AUTOPHAGY["AUTOPHAGY"] -->|"associated with"| TAU["TAU"]
APP["APP"] -->|"associated with"| TAU["TAU"]
ALS["ALS"] -->|"associated with"| TAU["TAU"]
end
subgraph Signaling["Signaling"]
TAU["TAU"] -->|"activates"| NEURODEGENERATION_1["NEURODEGENERATION"]
TAU["TAU"] -->|"activates"| Alzheimer["Alzheimer"]
TAU["TAU"] -->|"activates"| Als["Als"]
TAU["TAU"] -->|"activates"| Autophagy["Autophagy"]
TAU["TAU"] -->|"activates"| Oxidative_Stress["Oxidative Stress"]
end
style TAU fill:#006494,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0,font-weight:bold
style NEURODEGENERATION fill:#5d4400,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style NEURODEGENERATION_1 fill:#5d4400,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style ALZHEIMER_S_DISEASE fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style TAUOPATHY fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Alzheimer fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Als fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Autophagy fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Oxidative_Stress fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style Alzheimer_2 fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style AMYLOID fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style MICROGLIA fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style NEUROINFLAMMATION fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style AUTOPHAGY fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style APP fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
style ALS fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| SNCA | associated_with | gene | 1.00 |
| APOE | associated_with | gene | 1.00 |
| GFAP | biomarker_for | gene | 1.00 |
| NFL | biomarker_for | gene | 1.00 |
| PSEN1 | associated_with | gene | 1.00 |
| GFAP | associated_with | protein | 1.00 |
| NEURODEGENERATION | associated_with | phenotype | 1.00 |
| NEURODEGENERATION | activates | phenotype | 1.00 |
| ALZHEIMER'S DISEASE | associated_with | gene | 1.00 |
| TAUOPATHY | associated_with | gene | 1.00 |
| Alzheimer | activates | disease | 1.00 |
| Als | activates | disease | 1.00 |
| Autophagy | activates | pathway | 1.00 |
| Oxidative Stress | activates | pathway | 1.00 |
| Alzheimer | associated_with | disease | 1.00 |
| Alzheimer | interacts_with | disease | 1.00 |
| Tauopathy | activates | disease | 1.00 |
| Neurodegeneration | activates | disease | 1.00 |
| Als | therapeutic_target | disease | 1.00 |
| Neurodegeneration | therapeutic_target | disease | 1.00 |
| Alzheimer | regulates | disease | 1.00 |
| Als | regulates | disease | 1.00 |
| Alzheimer | inhibits | disease | 1.00 |
| Als | inhibits | disease | 1.00 |
| Neurodegeneration | inhibits | disease | 1.00 |
| NEUROINFLAMMATION | therapeutic_target | gene | 1.00 |
| Alzheimer | therapeutic_target | disease | 1.00 |
| Neuroinflammation | therapeutic_target | disease | 1.00 |
| Inflammation | therapeutic_target | disease | 1.00 |
| Tauopathy | associated_with | disease | 1.00 |
| Aging | therapeutic_target | disease | 1.00 |
| NEUROINFLAMMATION | associated_with | gene | 1.00 |
| Neuroinflammation | associated_with | disease | 1.00 |
| Inflammation | associated_with | disease | 1.00 |
| Als | contributes_to | disease | 1.00 |
| NEUROINFLAMMATION | activates | gene | 1.00 |
| Dementia | associated_with | disease | 1.00 |
| Neuroinflammation | activates | disease | 1.00 |
| Inflammation | activates | disease | 1.00 |
| Neurodegeneration | regulates | disease | 1.00 |
| Inflammation | inhibits | disease | 1.00 |
| Als | associated_with | disease | 1.00 |
| NEURODEGENERATIVE DISEASES | therapeutic_target | gene | 1.00 |
| ALZHEIMER'S DISEASE | therapeutic_target | gene | 1.00 |
| Dementia | therapeutic_target | disease | 1.00 |
| Aging | activates | disease | 1.00 |
| Neurodegeneration | associated_with | disease | 1.00 |
| ALZHEIMER'S DISEASE | activates | gene | 1.00 |
| Aging | associated_with | disease | 1.00 |
| Inflammation | interacts_with | disease | 1.00 |
| Source | Relation | Type | Str |
|---|---|---|---|
| APP | associated_with | gene | 1.00 |
| AKT | associated_with | gene | 1.00 |
| APOE | associated_with | gene | 1.00 |
| MAPT | associated_with | gene | 1.00 |
| TARDBP | associated_with | gene | 1.00 |
| AMYLOID | associated_with | gene | 1.00 |
| MICROGLIA | associated_with | gene | 1.00 |
| NEUROINFLAMMATION | associated_with | gene | 1.00 |
| AUTOPHAGY | associated_with | gene | 1.00 |
| ALS | associated_with | gene | 1.00 |
| ALZHEIMER'S DISEASE | activates | gene | 1.00 |
| ALZHEIMER'S DISEASE | associated_with | gene | 1.00 |
| NEURODEGENERATION | activates | gene | 1.00 |
| NEURODEGENERATION | therapeutic_target | gene | 1.00 |
| ALZHEIMER'S DISEASE | regulates | gene | 1.00 |
| MICROGLIA | activates | gene | 1.00 |
| ASTROCYTES | associated_with | gene | 1.00 |
| NEURODEGENERATION | associated_with | gene | 1.00 |
| PARKINSON'S DISEASE | associated_with | gene | 1.00 |
| AMYLOID | interacts_with | gene | 1.00 |
| AMYLOID | causes | gene | 1.00 |
| AMYLOID | activates | gene | 1.00 |
| AMYLOID | inhibits | gene | 1.00 |
| ALZHEIMER'S DISEASE | phosphorylates | gene | 1.00 |
| AMYLOID | phosphorylates | gene | 1.00 |
| NEURODEGENERATION | biomarker_for | gene | 1.00 |
| AMYLOID | regulates | protein | 1.00 |
| NF-KB | associated_with | protein | 1.00 |
| BDNF | associated_with | gene | 0.98 |
| CASP3 | associated_with | gene | 0.98 |
| APOPTOSIS | associated_with | gene | 0.98 |
| ALZHEIMER'S DISEASE | causes | gene | 0.98 |
| Glymphatic System | associated_with | process | 0.95 |
| Qingke Β-Glucan | associated_with | compound | 0.95 |
| RPS6KB1 | phosphorylates | gene | 0.95 |
| Glucose Deprivation | upregulates | process | 0.95 |
| PAR1 | phosphorylates | enzyme | 0.95 |
| MARK | phosphorylates | enzyme | 0.95 |
| VPS35 | regulates | protein | 0.95 |
| Alzheimer's Disease | associated_with | disease | 0.95 |
| NEUROFIBRILLARY TANGLES | interacts_with | protein | 0.95 |
| STEM CELLS | activates | cell_type | 0.95 |
| IPSC | activates | cell_type | 0.95 |
| Alzheimer'S Disease | associated_with | disease | 0.95 |
| PKR | phosphorylates | entity | 0.95 |
| Tau Phosphorylation | modulates | process | 0.95 |
| MTOR | associated_with | gene | 0.90 |
| FUS | associated_with | gene | 0.90 |
| HNRNPA2B1 | associated_with | protein | 0.90 |
| MEPCE | associated_with | protein | 0.90 |
Hypotheses where this entity is a therapeutic target
Scientific analyses that reference this entity
neurodegeneration | 2026-04-15 | 2 hypotheses Top: 0.636
neurodegeneration | 2026-04-15 | 2 hypotheses Top: 0.609
neurodegeneration | 2026-04-15 | 2 hypotheses Top: 0.455
neurodegeneration | 2026-04-15 | 0 hypotheses
neurodegeneration | 2026-04-14 | 1 hypotheses Top: 0.604
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Gray matter structural and molecular signatures in Alzheimer's disease and late- [PMID:41419068] | Yang S, Wang X, Yan Y, Zhang J, Wei Y et | J Affect Disord | 2026 | 0 |
| Duloxetine Improves Early Clinical Outcomes Including Range of Motion, Functiona [PMID:41934361] | Han SC, Han J, Min YK, Han JW, Jeong HJ | Am J Sports Med | 2026 | 0 |
| External fixation versus reverse shoulder arthroplasty for proximal humerus frac [PMID:41940987] | Vadalà A, Benelli C, Suraci F, Carta B, | Arch Orthop Trauma Surg | 2026 | 0 |
| Modeling and simulation of conducting airways during continuous high-frequency o [PMID:41941967] | Huang X, Francis I, Gu Y, Saha SC | Respir Physiol Neurobiol | 2026 | 0 |
| Potential antidepressant properties of aminophylline in male mice exposed to chr [PMID:41945313] | Samante FI, Galangue CG, Avelino DC, Bel | Pharmacol Rep | 2026 | 0 |
| Robot-assisted immediate implant placement with the socket shield technique in t [PMID:41963213] | Wu J, Lin B, Yang S, Xu S, Li S | J Prosthet Dent | 2026 | 0 |
| Fate plasticity of interneuron specification. [PMID:40264797] | Mostajo-Radji MA, Leon WRM, Breevoort A, | iScience | 2025 | 0 |
| Human stem cell-derived GABAergic interneuron development reveals early emergenc [PMID:40651475] | Bershteyn M, Zhou H, Fuentealba L, Chen | Neuron | 2025 | 0 |
| Forebrain assembloids support the development of fast-spiking human PVALB+ corti [PMID:40695284] | Walsh RM, Crabtree GW, Kalpana K, Jubier | Neuron | 2025 | 0 |
| Anterior cingulate cortex parvalbumin and somatostatin interneurons shape social [PMID:40320404] | Qi C, Sima W, Mao H, Hu E, Ge J et al. | Nat Commun | 2025 | 0 |
| Distinct dendritic integration strategies control dynamics of inhibition in the [PMID:40592329] | Morabito A, Zerlaut Y, Dhanasobhon D, Be | Neuron | 2025 | 0 |
| Targeting SARM1 improves autophagic stress-induced axonal neuropathy. [PMID:37561040] | Kim HR, Lee HJ, Jeon Y, Jang SY, Shin YK | Autophagy | 2024 | 0 |
| Integrated multimodal cell atlas of Alzheimer's disease. [PMID:39402379] | Gabitto MI, Travaglini KJ, Rachleff VM, | Nat Neurosci | 2024 | 0 |
| Identification of early Alzheimer's disease subclass and signature genes based o [PMID:39650656] | Wang W, Lu J, Pan N, Zhang H, Dai J et a | Front Immunol | 2024 | 0 |
| Cortical assembloids support the development of fast-spiking human PVALB+ cortic [PMID:39651135] | Walsh RM, Crabtree GW, Kalpana K, Jubier | bioRxiv | 2024 | 0 |
| Cortical somatostatin long-range projection neurons and interneurons exhibit div [PMID:38086373] | Fisher J, Verhagen M, Long Z, Moissidis | Neuron | 2024 | 0 |
| Locus Coeruleus-Dorsolateral Septum Projections Modulate Depression-Like Behavio [PMID:38155473] | Zhang Q, Xue Y, Wei K, Wang H, Ma Y et a | Adv Sci (Weinh) | 2024 | 0 |
| Somatostatin and the pathophysiology of Alzheimer's disease. [PMID:38484981] | Almeida VN | Ageing Res Rev | 2024 | 0 |
| Somatostatin interneurons control the timing of developmental desynchronization [PMID:38599213] | Mòdol L, Moissidis M, Selten M, Oozeer F | Neuron | 2024 | 0 |
| De novo gene synthesis by an antiviral reverse transcriptase. [PMID:39116258] | Tang S, Conte V, Zhang DJ, Žedaveinytė R | Science | 2024 | 0 |